share_log

Morgan Stanley Maintains Underweight on Avanos Medical, Raises Price Target to $28

Benzinga Real-time News ·  Feb 22, 2023 08:51

Morgan Stanley analyst Drew Ranieri maintains Avanos Medical (NYSE:AVNS) with a Underweight and raises the price target from $26 to $28.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment